AYTU
Aytu Biopharma
$2.06
−$0.10 (−4.63%)Jul 27, 2026
Key metrics
The numbers that frame AYTU today
- Market cap
- $22.11M
- P/E (TTM)
- -0.6
- EV / FCF
- 10.5
- Gross margin
- 64.8%
- EV / Sales
- 0.3
- ROIC
- -418.5%
- Div yield
- 0%
- Debt / equity
- 0.6
- 52wk Low
- $1.65
- 52wk High
- $3.07
Growth
Revenue and earnings trend for AYTU
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AYTU
Is Aytu Biopharma a good buy?
Hold. Aytu Biopharma has strong quality, but weak momentum makes the setup mixed. Growth looks mixed. The support signal is useful, but not decisive. We think Aytu Biopharma is selling at a fair price.
What is the market capitalization of AYTU?
Aytu Biopharma's market capitalization is $22.11M.
What is the P/E ratio for AYTU stock?
Aytu Biopharma's current P/E ratio is -0.6.
What is the 52-week high for AYTU stock?
The 52-week high for Aytu Biopharma is $3.07. The current close of $2.06 is 32.8% below that high.
What is the 52-week low for AYTU stock?
The 52-week low for Aytu Biopharma is $1.65. The current close of $2.06 is 24.8% above that low.
Does AYTU stock pay dividends?
Aytu Biopharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AYTU?
Aytu Biopharma's Debt / Equity ratio is 0.62.